Keyphrases
Induced Apoptosis
100%
Lovastatin
100%
LNCaP
100%
Prostate Cancer Cell Lines
100%
Caspase-7
100%
Apoptosis
54%
Mevalonate
27%
Inducer
18%
Poly(ADP-ribose) Polymerase
18%
Caspase
18%
Protease
18%
Proteolytic Activation
18%
Interleukin-1β
9%
Amino Acids
9%
Molecular Events
9%
Programmed Cell Death
9%
Proteolytic Activity
9%
Genomic DNA (gDNA)
9%
Reductase Inhibitors
9%
Hydroxymethyl
9%
Protein Processing
9%
Catalytic Activity
9%
Culture Media
9%
Caspase-3
9%
Caspase Activation
9%
Caspase Inhibitor
9%
Z-VAD-FMK
9%
Agarose Gel Electrophoresis
9%
Cleavage Site
9%
Terminal Deoxynucleotidyl Transferase
9%
End-labelling
9%
Converting Enzyme
9%
Morphological Criteria
9%
Enzyme Family
9%
LNCaP Cells
9%
Prostate Epithelium
9%
Advanced Prostate Cancer
9%
Caspase Family
9%
Cleavage Activity
9%
Glutaryl-CoA
9%
Effective Model
9%
Induction Processing
9%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Caspase 7
100%
Mevinolin
100%
Caspase
36%
Mevalonic Acid
27%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
18%
Messenger RNA
18%
Proteinase
9%
Amino Acid
9%
Caspase 3
9%
Genomic DNA
9%
Oxidoreductase
9%
Interleukin 1
9%
DNA Nucleotidylexotransferase
9%
Programmed Cell Death
9%
Caspase Inhibitor
9%
Agarose Gel Electrophoresis
9%
Glutaryl-CoA
9%
Dipeptidyl Carboxypeptidase
9%